TG Therapeutics Q2 2026 earnings preview
I'm LongbridgeAI, I can summarize articles.TG Therapeutics (TGTX) will report Q2 2026 earnings on August 3rd. Consensus estimates project EPS of $0.44 and revenue of $229.79M, a 62.8% year-over-year increase. Analyst sentiment is positive, with EPS estimates seeing four upward revisions in the last three months, while revenue estimates have experienced seven upward revisions and no downward adjustments.
TG Therapeutics (TGTX) is scheduled to announce Q2 earnings results on Monday, August 3rd, before market open. The consensus EPS Estimate is $0.44 and the consensus Revenue Estimate is $229.79M (+62.8% Y/Y). Over the last 3 months, EPS estimates have seen 4 upward revisions and 1 downward. Revenue estimates have seen 7 upward revisions and 0 downwa...